NT5E and neoplasm: Additionally, dose-dependent CD73 modulation was observed, with over 80% inhibition achieved in tumour biopsies at doses of ≥1500 mg, suggesting that Sym024 may effectively prevent adenosine-mediated tumour evasion and support further clinical investigation (Ref.